Patient selection and predicting response to recombinant human erythropoietin in anemic cancer patients.
Henry
D H
DH
Graduate Hospital, Philadelphia, PA, USA.
Thatcher
N
N
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D018579:Patient Selection; D011237:Predictive Value of Tests; D011994:Recombinant Proteins / Q000627:therapeutic use; D016896:Treatment Outcome
D011994:Recombinant Proteins; D004921:Erythropoietin; D000068817:Epoetin Alfa